Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Aripiprazole monotherapy can relieve ruminations in a case with nonpsychotic depression.

Hou YC, Lai CH.

J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):E32-3. doi: 10.1176/appi.neuropsych.13100324. No abstract available.

PMID:
26037881
2.

Effect of aripiprazole monotherapy in a patient presenting with delayed sleep phase syndrome associated with depressive symptoms.

Suzuki H, Hibino H, Inoue Y, Mikami K.

Psychiatry Clin Neurosci. 2018 May;72(5):375-376. doi: 10.1111/pcn.12650. Epub 2018 Apr 10. No abstract available.

3.

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.

Thase ME, Jonas A, Khan A, Bowden CL, Wu X, McQuade RD, Carson WH, Marcus RN, Owen R.

J Clin Psychopharmacol. 2008 Feb;28(1):13-20. doi: 10.1097/jcp.0b013e3181618eb4. Erratum in: J Clin Psychopharmacol. 2009 Feb;29(1):38.

PMID:
18204335
4.

Moderators of Remission in Patients With Late-Life Depression: Where Do We Go Next?

Taylor WD.

JAMA Psychiatry. 2016 Apr;73(4):319-20. doi: 10.1001/jamapsychiatry.2015.3458. No abstract available.

5.

Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN.

CNS Spectr. 2009 Apr;14(4):197-206.

PMID:
19407731
6.

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.

PMID:
21869699
8.

Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.

Wisniewski SR, Chen CC, Kim E, Kan HJ, Guo Z, Carlson BX, Tran QV, Pikalov A.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):965-72. doi: 10.1002/pds.1805.

PMID:
19662630
9.

Potential utility of aripiprazole monotherapy for the treatment of major depressive disorder comorbid with obsessive-compulsive disorder.

Pae CU.

Psychiatry Clin Neurosci. 2009 Aug;63(4):593. doi: 10.1111/j.1440-1819.2009.01990.x. No abstract available.

PMID:
19659566
10.

Aripiprazole monotherapy in a patient with major depressive disorder.

Yokoyama Y, Kitamura H, Someya T.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1124-5. doi: 10.1016/j.pnpbp.2010.04.008. Epub 2010 Apr 14. No abstract available.

PMID:
20398715
11.

Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.

Arbaizar B, Dierssen-Sotos T, Gómez-Acebo I, Llorca J.

Gen Hosp Psychiatry. 2009 Sep-Oct;31(5):478-83. doi: 10.1016/j.genhosppsych.2009.05.005. Epub 2009 Jun 23.

PMID:
19703642
12.

Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.

Schüle C, Baghai TC, Eser D, Hecht S, Hermisson I, Born C, Häfner S, Nothdurfter C, Rupprecht R.

World J Biol Psychiatry. 2007;8(2):112-22.

PMID:
17455104
13.

Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.

Trivedi MH, Thase ME, Fava M, Nelson CJ, Yang H, Qi Y, Tran QV, Pikalov A, Carlson BX, Marcus RN, Berman RM.

J Clin Psychiatry. 2008 Dec;69(12):1928-36. Epub 2008 Dec 2.

PMID:
19192475
14.

[Use of aripiprazole in the treatment of catatonia].

Vörös V, Tényi T.

Neuropsychopharmacol Hung. 2010 Jun;12(2):373-6. Hungarian.

15.

Aripiprazole as an adjunctive treatment for refractory major depression.

Hellerstein DJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1347-8. No abstract available.

PMID:
15588762
16.

The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.

Chen SJ, Hsiao YL, Shen TW, Chen ST.

J Clin Psychopharmacol. 2012 Feb;32(1):56-60. doi: 10.1097/JCP.0b013e31823f6c7f.

PMID:
22198444
17.
18.

Aripiprazole adjunctive to antidepressant therapy.

Marcus RM, Sanchez R, Frost M, McQuade RD.

Am J Psychiatry. 2011 Feb;168(2):211; author reply 211. doi: 10.1176/appi.ajp.2010.10101515. No abstract available.

PMID:
21297051
19.

Aripiprazole in refractory depression?

Carroll BJ.

J Clin Psychopharmacol. 2009 Feb;29(1):90-1; author reply 92-3. doi: 10.1097/JCP.0b013e318193c9b1. No abstract available.

PMID:
19142117
20.

Aripiprazole in depersonalization disorder comorbid with major depression and obsessive-compulsive disorder: 3 cases.

Uguz F, Sahingoz M.

Clin Neuropharmacol. 2014 Jul-Aug;37(4):125-7. doi: 10.1097/WNF.0000000000000036.

PMID:
24992087

Supplemental Content

Support Center